Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath.
Conclusions: Performance of cobas HPV for ASC-US triage in pretreated SurePath specimens meets criteria for validation. Preliminary data indicate reliable performance of HPV testing in a highly vaccinated population.
PMID: 29045515 [PubMed - as supplied by publisher]
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Tewari D, Novak-Weekley S, Hong C, Aslam S, Behrens CM Tags: Am J Clin Pathol Source Type: research
More News: Cervical Cancer Vaccine | Colposcopy | Cytology | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Pathology | Vaccines | Women